What are the treatment options for hyperhidrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Hyperhidrosis

For primary focal hyperhidrosis, begin with topical aluminum chloride 10-20% solution as first-line therapy, escalating to botulinum toxin injections for axillary disease or oral glycopyrrolate for craniofacial involvement when topical therapy fails. 1, 2

Initial Assessment and Diagnosis

Before initiating treatment, evaluate for secondary causes of hyperhidrosis by checking:

  • Thyroid function tests to exclude hyperthyroidism 1
  • Medication review for drugs causing excessive sweating 1
  • Iron stores, vitamin D, and zinc levels 1

Use the Hyperhidrosis Disease Severity Scale to grade severity and guide treatment intensity 2.

Treatment Algorithm by Anatomic Location

Axillary Hyperhidrosis

First-line therapy:

  • Topical aluminum chloride 10-20% solution applied to dry skin at bedtime 1, 2, 3
  • Note: May cause scalp irritation or scaling if used on the head 1

Second-line therapy:

  • OnabotulinumtoxinA (Botox) injections into affected areas 1, 2
  • Provides 3-6 months of relief but requires repeated treatments 3, 4
  • May cause temporary weakness in adjacent muscles depending on injection site 1

Third-line therapy:

  • Oral glycopyrrolate 1-2 mg twice daily 3
  • Common side effects include dry mouth, blurred vision, urinary retention, and constipation 1, 5
  • Contraindicated in glaucoma, paralytic ileus, unstable cardiovascular status, severe ulcerative colitis, and myasthenia gravis 5

Fourth-line therapy:

  • Local microwave therapy for axillary disease 2
  • Local surgical excision or curettage 3, 6

Fifth-line therapy:

  • Endoscopic thoracic sympathectomy (ETS) only after all other options exhausted 3
  • Risk of compensatory hyperhidrosis, gustatory sweating, Horner syndrome, and neuralgia 4

Palmar and Plantar Hyperhidrosis

First-line therapy:

  • Topical aluminum chloride 10-20% solution 2, 3

Second-line therapy:

  • Oral glycopyrrolate 1-2 mg once or twice daily (preferred) or clonidine 0.1 mg twice daily 3
  • Glycopyrrolate offers better efficacy with reasonable safety profile 3

Third-line therapy:

  • Tap water iontophoresis 2, 3, 6
  • High efficacy but requires ongoing maintenance treatments 4, 6
  • Adding anticholinergic substances to water produces more rapid and longer-lasting results 6

Fourth-line therapy:

  • Botulinum toxin injections 3
  • Highly effective but expensive, painful, and requires repeat treatments every 3-6 months 3, 4

Fifth-line therapy:

  • ETS for palmar hyperhidrosis only (not recommended for plantar due to anatomic risks) 3

Craniofacial Hyperhidrosis

First-line therapy:

  • Topical glycopyrrolate 1% solution/gel applied twice daily 2
  • Oral glycopyrrolate 1-2 mg once or twice daily or clonidine 0.1 mg twice daily 3

Second-line therapy:

  • OnabotulinumtoxinA injections 1, 3

Third-line therapy:

  • ETS for severe refractory cases 3

Adjunctive Measures

All patients should receive counseling on:

  • Avoiding triggers: spicy foods, caffeine, alcohol 1
  • Wearing moisture-wicking materials and appropriate headwear 1
  • Maintaining regular scalp hygiene to prevent secondary complications 1
  • Avoiding exposure to hot environments, especially when on anticholinergic medications 5

Special Considerations

Glycopyrrolate dosing specifics:

  • Administer at least 1 hour before or 2 hours after meals (high-fat meals reduce absorption) 5
  • Start at low dose and titrate gradually over weeks based on response and tolerability 5
  • Monitor closely for constipation (most common side effect requiring discontinuation) 5
  • Watch for urinary retention, particularly in patients with neurologic conditions 5

Monitoring:

  • Regular follow-up every 3-6 months to assess treatment response and medication side effects 1
  • Reassess severity using validated scales to guide treatment adjustments 2

Common Pitfalls to Avoid

  • Do not use incision and drainage for hyperhidrosis lesions (nearly 100% recurrence rate) 7
  • Avoid simple excision without considering deroofing techniques for chronic lesions 7
  • Do not escalate methylprednisolone above 2 mg/kg/day (no additional benefit) 7
  • Recognize that single environmental control interventions (like dust mite covers alone) are ineffective; multiple strategies may be needed 7

References

Guideline

Treatment Options for Hyperhidrosis of the Head and Hair

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperhidrosis: Management Options.

American family physician, 2018

Research

Treatment options for hyperhidrosis.

American journal of clinical dermatology, 2011

Research

Current therapeutic strategies for hyperhidrosis: a review.

European journal of dermatology : EJD, 2002

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.